Skip to main content

Advertisement

SpringerLink
Log in

Development of gastric cancer associated with Helicobacter pylori infection

  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

Helicobacter pylori infection is associated with histological gastritis, gastric atrophy, gastric cancer and mucosa-associated lymphoid tissue lymphoma in the stomach. However, gastric cancer only develops in a minority of infected individuals. Such clinical diversity is caused by variations in the interactions between H. pylori pathogenicity, host susceptibility, and environmental factors. Based on evidence from three prospective epidemiological studies, the International Agency for Research on Cancer and the World Health Organization (IARC/WHO) concluded in 1994 that H. pylori has a causal linkage to gastric carcinogenesis and is a definite carcinogen in humans. Two large-scale, prospective, epidemiological studies have recently been reported in Japan and have confirmed that H. pylori infection constitutes a high risk factor for the development of gastric cancer, at least in males. In order to obtain evidence that eradication of H. pylori leads to a reduction in the occurrence of gastric cancer, reversibility of precancerous lesions, gastric atrophy or intestinal metaplasia should be proven after eradication treatment. A biopsy specimen from the lesser curvature of the corpus is the most sensitive for evaluating the regression of gastric atrophy on histology, and the evaluation needs be conducted at least 13 months after treatment. In a Mongolian gerbil model with or without low-dose chemical carcinogens, it has been demonstrated that H. pylori can lead to the development of gastric cancer. Experimental studies have elucidated that virulence factors of H. pylori interact with gastric epithelial cell signaling related to carcinogenesis. The cag pathogenicity island (cagPAI) is a major virulence gene cluster; it encodes the type IV secretion machinery system forming a cylinder-like structure. The CagA protein is translocated into target cells via this secretion system and induces a hummingbird phenotype, a growth factor-like effect. The other gene products are probably translocated into target cells and accelerate cellular proliferation and apoptosis. The molecular mechanism of the interaction between H. pylori and gastric epithelial cells may provide a new strategy for effective prevention of the development of gastric cancer induced by H. pylori infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Asaka M, Satoh K, Sugano K, Sugiyama T, Takahashi S, Fukuda Y, Ota H, Murakami K, Kimura K, Shimoyama T (2001) Guidelines in the management of Helicobacter pylori infection in Japan. Helicobacter 6:177

    Article  CAS  PubMed  Google Scholar 

  2. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A (1995) Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 55:2111

    CAS  PubMed  Google Scholar 

  3. Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, Rappuoli R, Covacci A (1996) cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A 93:14648

    Article  CAS  PubMed  Google Scholar 

  4. Correa P, Fontham ET, Bravo JC, Bravo LE, Ruiz B, Zarama G, Realpe JL, Malcom GT, Li D, Johnson WD, Mera R (2000) Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplement and anti-Helicobacter pylori therapy. J Natl Cancer Inst 92:1881

    Article  CAS  PubMed  Google Scholar 

  5. Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R (1999) Helicobacter pylori virulence and genetic geography. Science 284:1328

    Article  CAS  PubMed  Google Scholar 

  6. Dixon MF, Genta RM, Yardley JH, Correa P (1996) Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 20:1161

    Article  CAS  PubMed  Google Scholar 

  7. European Helicobacter Pylori Study Group (1997) Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 41:8

    PubMed  Google Scholar 

  8. Forman D, Newell DG, Fullerton F, Yarnell JW, Stacey AR, Wald N, Sitas F (1991) Association between infection of Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 302:1302

    CAS  PubMed  Google Scholar 

  9. Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M, Hatakeyama M (2002) SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 295:683

    Article  CAS  PubMed  Google Scholar 

  10. Hirayama F, Takagi S, Kusuhara H, Iwao E, Yokoyama Y, Ikeda Y (1996) Induction of gastric ulcer and intestinal metaplasia in Mongolian gerbils infected with Helicobacter pylori. J Gastroenterol 31:755

    CAS  PubMed  Google Scholar 

  11. Hirayama F, Takagi S, Iwao E, Yokoyama Y, Haga K, Hanada S (1999) Development of poorly differentiated adenocarcinoma and carcinoid due to long-term Helicobacter pylori colonization in Mongolian gerbils. J Gastroenterol 34:450

    Article  CAS  PubMed  Google Scholar 

  12. International Agency for Research on Cancer (1994) IARC Monographs on the evaluation of carcinogenic risk to humans, vol 61: Schistosomotes, liver flukes and Helicobacter pylori. IARC, Lyon, France

  13. Keates S, Sougioultzis S, Keates AC, Zhao D, Peek RM Jr, Shaw LM, Kelly CP (2001) cag+ Helicobacter pylori induce transactivation of the epidermal growth factor receptor in AGS gastric epithelial cells. J Biol Chem 276:48127

    Article  CAS  PubMed  Google Scholar 

  14. Lai YP, Yang JC, Lin TZ, Wang JT, Lin JT (2003) CagA tyrosine phosphorylation in gastric epithelial cells caused by Helicobacter pylori in patients with gastric adenocarcinoma. Helicobacter 8:235

    Article  CAS  PubMed  Google Scholar 

  15. Lam SK, Tally NJ (1998) Helicobacter pylori consensus. Report of the 1997 Asian Pacific Consensus Conference on the Management of Helicobacter pylori Infection. J Gastroenterol Hepatol 13:1

    CAS  PubMed  Google Scholar 

  16. Marchildon PA, Sugiyama T, Fukuda Y, Peacock JS, Asaka M, Shimoyama T, Graham DY (2003) Evaluation of the effects of strain-specific antigen variation on the accuracy of serologic diagnosis of Helicobacter pylori infection. J Clin Microbiol 41:1480

    Article  PubMed  Google Scholar 

  17. Meyer-ter-Vehn T, Covacci A, Kist M, Pahl HL (2000) Helicobacter pylori activates mitogen-activated protein kinase cascades and induces expression of the proto-oncogenes c-fos and c-jun. J Biol Chem 275:16064

    Article  CAS  PubMed  Google Scholar 

  18. Mimuro H, Suzuki T, Tanaka J, Asahi M, Haas R, Sasakawa C (2002) Grb 2 is a key mediator of Helicobacter pylori CagA protein activities. Mol Cell 10:745

    Article  CAS  PubMed  Google Scholar 

  19. Mizushima T, Sugiyama T, Komatsu Y, Ishizuka J, Kato M, Asaka M (2001) Clinical relevance of the babA2 genotype of Helicobacter pylori in Japanese clinical isolates. J Clin Microbiol 39:2463

    Article  CAS  PubMed  Google Scholar 

  20. Nagasako T, Sugiyama T, Mizushima T, Miura Y, Kato M, Asaka M (2003) Upregulated Smad 5 mediates apoptosis of gastric epithelial cells induced by Helicobacter pylori infection. J Biol Chem 278:4821

    Article  CAS  PubMed  Google Scholar 

  21. NIH Consensus Conference (1994) Helicobacter pylori in peptic ulcer disease. JAMA 272:65

    PubMed  Google Scholar 

  22. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ (1991) Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 325:1132

    CAS  PubMed  Google Scholar 

  23. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK (1991) Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127

    CAS  PubMed  Google Scholar 

  24. Potthoff A, Ledig S, Martin J, Jandl O, Cornberg M, Obst B, Beil W, Manns MP, Wagner S (2002) Significance of the caspase family in Helicobacter pylori induced gastric epithelial apoptosis. Helicobacter 7:367

    Article  CAS  PubMed  Google Scholar 

  25. Rudi J, Kuck D, Strand S, von Herbay A, Mariani SM, Krammer PH, Galle PR, Stremmel W (1998) Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis. J Clin Invest 102:1506

    CAS  PubMed  Google Scholar 

  26. Shimizu N, Inada K, Nakanishi H, Tsukamoto T, Ikehara Y, Kaminishi M, Kuramoto S, Sugiyama A, Katsuyama T, Tatematsu M (1999) Helicobacter pylori infection enhances glandular stomach carcinogenesis in Mongolian gerbil treated with chemical carcinogens. Carcinogenesis 20:669

    Article  CAS  PubMed  Google Scholar 

  27. Shimizu N, Ikehara Y, Inada K, Nakanishi H, Tsukamoto T, Nozaki K, Kaminishi M, Kuramoto S, Sugiyama A, Katsuyama T, Tatematsu M (2000) Eradication diminishes enhancing effects of Helicobacter pylori infection on glandular stomach carcinogenesis in Mongolian gerbils. Cancer Res 60:1512

    CAS  PubMed  Google Scholar 

  28. Sugiyama A, Maruta F, Ikeno T, Ishida K, Kawasaki S, Katsuyama T, Shimizu N, Tatematsu M (1998) Helicobacter pylori infection enhances N-methyl-N-nitrosourea-induced stomach carcinogenesis in the Mongolian gerbil. Cancer Res 58:2067

    CAS  PubMed  Google Scholar 

  29. Sugiyama T, Sakaki N, Kozawa H, Sato R, Fujioka T, Satoh K, Sugano K, Sekine H, Takagi A, Ajioka Y, Takizawa T; for the Helicobacter Pylori Forum Gastritis Study Group (2002) Sensitivity of biopsy site in evaluating regression of gastric atrophy after Helicobacter pylori eradication treatment. Aliment Pharmacol Ther 16:187

    Article  PubMed  Google Scholar 

  30. Sung JJ, Lin SR, Ching JY, Zhou LY, To KF, Wang RT, Leung WK, Ng EK, Lau JY, Lee YT, Yeung CK, Chao W, Chung SC (2000) Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology 119:7

    Google Scholar 

  31. Tomb JF, White O, Kerlavage AR, Clayton RA, Sutton GG, Fleischmann RD, Ketchum KA, Klenk HP, Gill S, Dougherty BA, Nelson K, Quackenbush J, Zhou L, Kirkness EF, Peterson S, Loftus B, Richardson D, Dodson R, Khalak HG, Glodek A, McKenney K, Fitzgerald LM, Lee N, Adams MD, Venter JC, et al (1997) The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388:539

    Article  CAS  PubMed  Google Scholar 

  32. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345:784

    Article  CAS  PubMed  Google Scholar 

  33. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M (1998) Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology 115:642

    Google Scholar 

  34. Xia HH, Talley NJ (2001) Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis. Am J Gastroenterol 96:16

    Article  CAS  PubMed  Google Scholar 

  35. Yamagata H, Kiyohara Y, Aoyagi K, Kato I, Iwamoto H, Nakayama K, Shimizu H, Tanizaki Y, Arima H, Shinohara N, Kondo H, Matsumoto T, Fujishima M (2000) Impact of Helicobacter pylori infection on gastric cancer incidence in a general Japanese population: the Hisayama study. Arch Intern Med 160:1962

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterology, Hokkaido University Graduate School of Medicine, North 15, West 7, Kita-ku, 060-8638, Sapporo, Japan

    Toshiro Sugiyama

Authors
  1. Toshiro Sugiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Toshiro Sugiyama.

Additional information

This work was presented at the 19th Bristol-Myers Squibb Nagoya International Cancer Treatment Symposium, “State of the Arts for Digestive Organs”, 14–15 November 2003, Nagoya, Japan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sugiyama, T. Development of gastric cancer associated with Helicobacter pylori infection. Cancer Chemother Pharmacol 54 (Suppl 1), S12–S20 (2004). https://doi.org/10.1007/s00280-004-0881-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00280-004-0881-3

Keywords

Search

Navigation